A decade of integrated drug discovery at Symeres
Symeres celebrates a decade of integrated drug discovery. Our team has been working hard to provide our clients with the best possible solutions for their needs.
Symeres welcomes Karen Damian to the team
We introduce you to our newest Director of Business Development. Karen Damian has a history in the drug development life sciences business.
π-Facial selectivity in the Diels–Alder reaction of glucosamine-based chiral furans and maleimides
Symeres explorations into opportunities to access novel chemical space by using carbohydrates as sustainable chiral starting materials for library synthesis has led to yet another publication.
An interview with Yadan Chen and Paul O’Shea
We are pleased to introduce the founders of Symeres’ daughter company Exemplify in New Jersey: Yadan Chen, CEO, and Paul O’Shea, Chief Scientific Officer. Who are they? What do they stand for? And how does Exemplify fit with Symeres?
We’re expanding our laboratory facilities in Boston
To continue supporting our clients, our daughter company Organix needs more room. The new facility will help us expand our services.
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
We are proud to announce the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays.
Symeres CZ passed commercial inspection
We’re very keen on keeping our GMP facilities up to date according to the latest standards.
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US
Another strategic move. Exemplify has expertise and consultancy services in Process Chemistry, expertise and consultancy services in Process Chemistry, Analytical Chemistry, and Formulation Development.
Symeres to host final of Dutch Chemistry Olympiad 2025
What seems far away will be here before you know it. With our footprint in the Netherlands and our roots in chemistry, we are proud to have been asked to sponsor this event.
An interview with Anu Mahadevan and Paul Blundell
We proudly introduce the founders of Symeres’ daughter company Organix in Boston: Anu Mahadevan, CEO, and Paul Blundell, President at Organix. Who are they? What do they stand for? And how does Organix fit with Symeres?
Dr Laszlo Szilagyi joins Symeres to support our EU and APAC activities.
Laszlo Szilagyi recently joined us to support the team of our daughter company Admescope. We were curious to meet the newest addition to their team.
Expansion of Solid-State Center of Excellence
At Symeres, we’ve doubled our Solid-State laboratory facilities in the Netherlands […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.